Dow Up 0.76% Nasdaq Up 0.69%

Seattle Genetics Inc. (SGEN)

-NasdaqGS
35.95 Up 0.35(0.98%) 4:00PM EDT
|After Hours : 35.95 0.00 (0.00%) 4:57PM EDT
Prev Close:35.60
Open:35.52
Bid:35.92 x 1000
Ask:37.13 x 200
1y Target Est:44.92
Beta:2.2
Next Earnings Date:30-Oct-14SGEN Earnings announcement
Day's Range:34.92 - 36.31
52wk Range:30.80 - 55.99
Volume:935,702
Avg Vol (3m):1,011,660
Market Cap:4.44B
P/E (ttm):N/A
EPS (ttm):-0.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SGEN

Comparison

Symbol% ChgMkt Cap
SGENUp 0.98%4.44B
IMGNDown 5.10%751.69M
PFEUp 1.78%184.58B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.98
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.80
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):9.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback